TRACON Pharmaceuticals Inc (TCON)
1.53
+0.03
(+2.00%)
USD |
NASDAQ |
May 23, 10:04
TRACON Pharmaceuticals Cash from Financing (Quarterly): 1.87M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.87M |
| December 31, 2023 | 1.324M |
| September 30, 2023 | -9.091M |
| June 30, 2023 | 1.048M |
| March 31, 2023 | -5.82M |
| December 31, 2022 | 4.945M |
| September 30, 2022 | 10.47M |
| June 30, 2022 | 4.959M |
| March 31, 2022 | -0.686M |
| December 31, 2021 | -0.706M |
| September 30, 2021 | 12.75M |
| June 30, 2021 | -0.628M |
| March 31, 2021 | -0.86M |
| December 31, 2020 | 13.31M |
| September 30, 2020 | 16.27M |
| June 30, 2020 | 4.174M |
| March 31, 2020 | 3.014M |
| December 31, 2019 | 1.602M |
| September 30, 2019 | -0.70M |
| June 30, 2019 | 0.024M |
| Date | Value |
|---|---|
| March 31, 2019 | -0.02M |
| December 31, 2018 | 0.015M |
| September 30, 2018 | -0.016M |
| June 30, 2018 | 1.041M |
| March 31, 2018 | 34.28M |
| December 31, 2017 | 0.919M |
| September 30, 2017 | 2.53M |
| June 30, 2017 | 0.001M |
| March 31, 2017 | -0.124M |
| December 31, 2016 | 15.29M |
| September 30, 2016 | 4.00M |
| June 30, 2016 | 0.121M |
| March 31, 2016 | 0.007M |
| December 31, 2015 | 2.074M |
| September 30, 2015 | 0.039M |
| June 30, 2015 | -0.753M |
| March 31, 2015 | 35.09M |
| December 31, 2014 | -1.011M |
| September 30, 2014 | 27.20M |
| June 30, 2014 | 4.843M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-9.091M
Minimum
Sep 2023
16.27M
Maximum
Sep 2020
2.863M
Average
1.463M
Median
Cash from Financing (Quarterly) Benchmarks
| BioSig Technologies Inc | 1.54M |
| Revolution Medicines Inc | 0.81M |
| Perspective Therapeutics Inc | 166.33M |
| Electromed Inc | 0.056M |
| Xtant Medical Holdings Inc | 5.179M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.543M |
| Free Cash Flow | 6.136M |
| Free Cash Flow Per Share (Quarterly) | -21.28 |
| Free Cash Flow to Equity (Quarterly) | -2.543M |
| Free Cash Flow Yield | 292.7% |